Clinical trials
Completed Phase 1/2 Endometrial Neoplasms trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
23 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 1 |
| 2001 | 1 |
| 2006 | 1 |
| 2007 | 1 |
| 2012 | 2 |
| 2013 | 1 |
| 2014 | 1 |
| 2015 | 1 |
| 2016 | 6 |
| 2017 | 4 |
| 2018 | 2 |
| 2020 | 1 |
| 2022 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 23 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Incyte Biosciences International Sàrl | 2 |
| Incyte Corporation | 2 |
| Seagen Inc. | 2 |
| AGO Study Group | 1 |
| Ability Pharmaceuticals SL | 1 |
| COL George Peoples, MD, FACS | 1 |
| Centre de recherche du Centre hospitalier universitaire de Sherbrooke | 1 |
| Compugen Ltd | 1 |
| Esperas Pharma Inc. | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Endometrial Neoplasms | 23 |
| Ovarian Neoplasms | 15 |
| Uterine Cervical Neoplasms | 9 |
| Melanoma | 7 |
| Triple Negative Breast Neoplasms | 7 |
| Carcinoma, Non-Small-Cell Lung | 6 |
| Sarcoma | 6 |
| Breast Neoplasms | 5 |
| Esophageal Neoplasms | 5 |
| Carcinoma, Hepatocellular | 4 |
Trials
Showing 1 to 23 of 23. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.